HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Revenue
HUTCHMED (China) Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Revenue
$838m
|
CAGR 3-Years
54%
|
CAGR 5-Years
31%
|
CAGR 10-Years
34%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Revenue
HK$10.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Revenue
¥13.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Revenue
¥26.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Revenue
¥18.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
29%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Revenue
HK$244.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Revenue?
Revenue
838m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Revenue amounts to 838m USD.
What is HUTCHMED (China) Ltd's Revenue growth rate?
Revenue CAGR 10Y
34%
Over the last year, the Revenue growth was 97%. The average annual Revenue growth rates for HUTCHMED (China) Ltd have been 54% over the past three years , 31% over the past five years , and 34% over the past ten years .